Thailand Reclassifies High-Fluoride Oral Products as 'Dangerous Drugs'

According to a report by Matichon Online on August 20, 2026, the Thai Ministry of Public Health has issued a new regulatory classification for oral health products. Specifically, any medication or product intended for oral use that contains a fluoride concentration of 5,000 parts per million (ppm) is now officially categorized as a 'dangerous drug'.

For residents and travelers in Thailand, this regulatory update is significant as it implies stricter oversight regarding the sale, distribution, and accessibility of high-fluoride dental products. While standard over-the-counter toothpaste typically contains lower concentrations, individuals who rely on high-fluoride prescriptions or specialized dental treatments should be aware that these items may now be subject to more rigorous control measures under Thai law.

At this stage, the specific implications for consumers—such as whether these products will require a pharmacist's consultation or a doctor's prescription for purchase—remain to be fully clarified by the authorities. It is also currently unconfirmed how this reclassification will affect the availability of imported dental products that previously fell outside of this specific regulatory category. Residents and visitors are advised to consult with local healthcare professionals or pharmacists regarding the status of any high-fluoride products they currently use or intend to purchase.